Lancet HIV

Lancet HIV(英文缩写 LANCET HIV),ISSN 2352-3018,eISSN 2352-3018 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。

指标来源：jcr_cas_ifqb

历年影响因子趋势

Lancet HIV 最新收录文献

1. Turkish Government crackdown on HIV and LGBTQ+ groups.
   The Lancet Hiv
   The lancet. HIV 2026 IF: 14.60 Q1 PMID: 42759529
   查看详情 DOI
2. Expediting a UNIVERSAL first-line regimen of a dolutegravir-emtricitabine-tenofovir alafenamide fixed-dose ratio for children living with HIV older than 4 weeks: a 24-week, open-label, single-arm, phase 1-2, pharmacokinetic, safety, and antiviral activity trial.
   Anne E M Kamphuis, Nicolas Salvadori, Hilda Angela Mujuru, Mutsawashe Bwakura-Dangarembizi, Grace Paul Kisitu, Frank Matovu
   The lancet. HIV 2026 IF: 14.60 Q1 PMID: 42705257

   Paediatric antiretroviral fixed-dose combination tablets remain limited. UNIVERSAL1 evaluated pharmacokinetics, short-term safety, and antiviral activity of novel fixed-dose ratios of dolutegravir, em…

   查看详情 DOI
3. Advancing a fixed-dose combination for children with HIV.
   Sharon Nachman
   The lancet. HIV 2026 IF: 14.60 Q1 PMID: 42705256
   查看详情 DOI
4. Low-level viraemia in children living with HIV.
   Bianca Alvarez, Patricia Agaba, Rosemary Mrina, Meagan Stephenson, Shirley Lecher
   The lancet. HIV 2026 IF: 14.60 Q1 PMID: 42692046
   查看详情 DOI
5. Occupational HIV monitoring should match standard of care.
   Matthew Kneale
   The lancet. HIV 2026 IF: 14.60 Q1 PMID: 42648296
   查看详情 DOI
6. Will the new UN political declaration deliver?
   The Lancet Hiv
   The lancet. HIV 2026 IF: 14.60 Q1 PMID: 42648295
   查看详情 DOI
7. Highlights of AIDS 2026.
   Adrian Gonzalez Lopez
   The lancet. HIV 2026 IF: 14.60 Q1 PMID: 42561986
   查看详情 DOI
8. Evolving understanding of Kaposi sarcoma and associated diseases in the ART era.
   Nazzarena Labo, Elena M Cornejo Castro, Vickie A Marshall, Fahmida Shaik, Anisa Mosam, Susana Lazarte
   The lancet. HIV 2026 IF: 14.60 Q1 PMID: 42561985

   Kaposi sarcoma (KS)-associated herpesvirus (KSHV), otherwise known as HHV-8, causes KS and several lymphoproliferative disorders including KSHV-associated multicentric Castleman disease, KSHV-associat…

   查看详情 DOI
9. Interventions to improve viral suppression and adherence to antiretroviral therapy among people living with HIV: a systematic review and network meta-analysis.
   Steve Kanters, David S Lawrence, Vanessa S McLennan, Catherine Orrell, Clarice Pinto, Roger Chou
   The lancet. HIV 2026 IF: 14.60 Q1 PMID: 42556371

   In 2025, 78% of people living with HIV worldwide were on antiretroviral therapy 95% of people on treatment were virally suppressed. Suboptimal adherence, defined as not taking interventions as prescri…

   查看详情 DOI
10. Does U=U apply during breastfeeding? An urgent research priority.
    Dvora Joseph Davey, Shahin Lockman, Roger Shapiro, Thokozile Malaba, Natasha Davies, Lee Fairlie
    The lancet. HIV 2026 IF: 14.60 Q1 PMID: 42537676

    Whether undetectable equals untransmittable (U=U) applies during breastfeeding remains one of the most consequential unanswered questions in HIV prevention. Although sustained viral suppression elimin…

    查看详情 DOI